APG101

Known as: CD95 ECD/IgG-Fc Fusion Protein APG101 
A human, soluble fusion protein consisting of the extracellular domain of the CD95 receptor fused to the Fc-domain of the human IgG antibody, with… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2018
0120112018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
CD95 (Fas/APO-1), a death receptor family member, activity has been linked to tumorigenicity in multiple cancers, including… (More)
Is this relevant?
2016
2016
CD95, a member of the death receptor family initiates a caspase-dependent apoptosis, when activated by its ligand CD95L, thought… (More)
Is this relevant?
2015
2015
Glioblastoma is a disease characterized by rapid invasive tumour growth. Studies on the proapoptotic CD95/CD95L signalling… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
PURPOSE Preclinical data indicate anti-invasive activity of APG101, a CD95 ligand (CD95L)-binding fusion protein, in glioblastoma… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
Is this relevant?
2014
2014
Purpose: Preclinical data indicate anti-invasive activity of APG101, a CD95 ligand (CD95L)–binding fusion protein, in… (More)
  • figure 1
  • table 1
  • figure 2
  • table 3
Is this relevant?
2013
2013
Graft-versus-host disease (GVHD) induced by transplant-derived T cells represents a major complication after allogeneic bone… (More)
Is this relevant?
2012
2012
APG101 is a glycosylated fusion protein consisting of the extracellular domain of human CD95 (APO-1/Fas) and the Fc domain of… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2011
Review
2011
Insights into the molecular pathogenesis of glioblastoma have not yet resulted in relevant clinical improvement. With standard… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?